Home > Financial Ratios > CAPLIN POINT LABORATORIES

CAPLIN POINT LABORATORIES
Core EBITDA Margin

    Back to All Ratios
CAPLIN POINT LABORATORIES is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Best Quarterly Growth Small Cap Stocks
Best 1M Momentum Small Cap Stocks
COMMUNITY POLL
for CAPLIN POINT LABORATORIES
Please provide your vote to see the results

CAPLIN POINT LABORATORIES Last 5 Year Core EBITDA Margin History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
   Core EBITDA Margin(%) 34.7933.3932.5530.0331.08

What is the latest Core EBITDA Margin ratio of CAPLIN POINT LABORATORIES ?

The latest Core EBITDA Margin ratio of CAPLIN POINT LABORATORIES is 34.79 based on Mar2026 Consolidated results.
Year Core EBITDA Margin
Mar202634.79
Mar202533.39
Mar202432.55
Mar202330.03
Mar202231.08

How is Core EBITDA Margin of CAPLIN POINT LABORATORIES Trending?

Years Core EBITDA Margin % Change
Mar2026 34.79
4.19
Mar2025 33.39
2.58
Mar2024 32.55
8.39
Mar2023 30.03
-3.38
Mar2022 31.08 -

Other Financial Ratios of CAPLIN POINT LABORATORIES


Compare Core EBITDA Margin ratio of peers of CAPLIN POINT LABORATORIES

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
CAPLIN POINT LABORATORIES ₹20,936.1 Cr -2.1% 10.3% 28.4% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹441,958.0 Cr -3% -5.2% 17.9% Stock Analytics
DIVIS LABORATORIES ₹247,576.0 Cr 0.2% 9.7% 56.1% Stock Analytics
TORRENT PHARMACEUTICALS ₹189,233.0 Cr 1.3% 2% 36.5% Stock Analytics
CIPLA ₹110,273.0 Cr -2.2% -6.6% -10.5% Stock Analytics
DR REDDYS LABORATORIES ₹96,906.4 Cr 1.4% -3.7% -8.8% Stock Analytics


CAPLIN POINT LABORATORIES Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
CAPLIN POINT LABORATORIES

-2.1%

10.3%

28.4%

SENSEX

-2.3%

-4.1%

-7.4%


You may also like the below Video Courses